NEW YORK (GenomeWeb News) – Pacific Biosciences reported after the close of market on Thursday that while its second quarter 2013 revenues dropped roughly 18 percent year over year, its revenues grew 7 percent sequentially.

The Menlo Park, Calif.-based single-molecule sequencing technologies firm reported total revenues of $6 million for the three months ended June 30, compared to $7.3 million in the second quarter of 2012, and $5.6 million in the first quarter of 2013. It fell just shy of the consensus Wall Street estimate for revenues of $6.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.